Tuberculosis drug discovery in the post-post-genomic era

@inproceedings{Lechartier2014TuberculosisDD,
  title={Tuberculosis drug discovery in the post-post-genomic era},
  author={Benoit Lechartier and Jan Rybniker and Alimuddin M. Zumla and Stewart T Cole},
  booktitle={EMBO molecular medicine},
  year={2014}
}
The expectation that genomics would result in new therapeutic interventions for infectious diseases remains unfulfilled. In the post-genomic era, the decade immediately following the availability of the genome sequence of Mycobacterium tuberculosis, tuberculosis (TB) drug discovery relied heavily on the target-based approach but this proved unsuccessful leading to a return to whole cell screening. Genomics underpinned screening by providing knowledge and many enabling technologies, most… CONTINUE READING
43 Citations
75 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 75 references

A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis

  • PA Mak, SP Rao, +7 authors J Duraiswamy
  • ACS Chem Biol
  • 2012
2 Excerpts

Similar Papers

Loading similar papers…